id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CDC-2025-0651-0002,CDC,CDC-2025-0651,Draft-IC-in-HCP-Update-Conjunctivitis-Section,Supporting & Related Material,,2025-12-11T05:00:00Z,2025,12,,,2025-12-11T18:55:02Z,,0,0,09000064b90c5a1b
CDC-2025-0651-0003,CDC,CDC-2025-0651,Draft-IC-in-HCP-Update-Conjunctivitis-Supplement,Supporting & Related Material,,2025-12-11T05:00:00Z,2025,12,,,2025-12-11T18:55:12Z,,0,0,09000064b90c5a1c
CDC-2025-0651-0004,CDC,CDC-2025-0651,HCP-GL-Update-Selected-Infections-Methods-Appendix2,Supporting & Related Material,,2025-12-11T05:00:00Z,2025,12,,,2025-12-11T18:55:18Z,,0,0,09000064b90c602d
CDC-2024-0090-0020,CDC,CDC-2024-0090,VSP 2025 Standards - Change Request Tracking Spreadsheet,Supporting & Related Material,,2025-10-03T04:00:00Z,2025,10,,,2025-10-04T00:33:32Z,,0,0,09000064b8ff08d1
CDC-2024-0090-0018,CDC,CDC-2024-0090,2025 VSP Environmental Public Health Standards (final),Supporting & Related Material,,2025-07-15T04:00:00Z,2025,7,,,2025-07-15T22:37:32Z,,0,0,09000064b8e75ca3
CDC-2024-0090-0019,CDC,CDC-2024-0090,2025 VSP Construction Standards (final),Supporting & Related Material,,2025-07-15T04:00:00Z,2025,7,,,2025-07-15T22:37:37Z,,0,0,09000064b8e75ca4
CDC-2019-0093-0009,CDC,CDC-2019-0093,Final Revised - Immediately Dangerous to Life or Health (IDLH) Value Profile for Hydrogen Iodide,Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T06:57:03Z,,0,0,09000064b8e2a588
CDC-2019-0093-0006,CDC,CDC-2019-0093,"Final - Immediately Dangerous to Life or Health Values for 
Hydrogen Bromide",Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T06:49:00Z,,0,0,09000064b8e2d6d0
CDC-2019-0093-0007,CDC,CDC-2019-0093,Revised Final - Immediately Dangerous to Life or Health Values for Hydrogen Bromide,Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T06:50:24Z,,0,0,09000064b8e2d6d1
CDC-2023-0057-0004,CDC,CDC-2023-0057,Revised - Immediately Dangerous to Life or Health (IDLH) Value Profile: Hydrogen Chloride CAS® No. 7647-01-0,Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T05:13:14Z,,0,0,09000064b8e2da37
CDC-2019-0093-0008,CDC,CDC-2019-0093,Final - Immediately Dangerous to Life or Health (IDLH) Value Profile for Hydrogen Iodide,Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T06:54:17Z,,0,0,09000064b8e2a587
CDC-2023-0057-0003,CDC,CDC-2023-0057,Immediately Dangerous to Life or Health (IDLH) Value Profile: Hydrogen Chloride CAS® No. 7647-01-0,Supporting & Related Material,,2025-06-24T04:00:00Z,2025,6,,,2025-06-25T05:06:43Z,,0,0,09000064b8e2da36
CDC-2025-0001-0004,CDC,CDC-2025-0001,0920-0666 Correction_17JAN2025,Supporting & Related Material,,2025-01-22T05:00:00Z,2025,1,,,2025-01-22T13:44:13Z,,0,0,09000064868e9301
CDC-2020-0046-0150,CDC,CDC-2020-0046,NIOSH Final Reevaluation Determination of Pertuzumab on the NIOSH List of Hazardous Drugs in Healthcare Settings,Supporting & Related Material,,2024-12-20T05:00:00Z,2024,12,,,2024-12-20T12:19:40Z,,0,0,090000648687ad6b
CDC-2020-0046-0148,CDC,CDC-2020-0046,"NIOSH List of Hazardous Drugs in Healthcare Settings, 2024",Supporting & Related Material,,2024-12-20T05:00:00Z,2024,12,,,2024-12-20T12:13:24Z,,0,0,090000648687ad6c
CDC-2020-0046-0149,CDC,CDC-2020-0046,NIOSH Final Reevaluation Determination of Liraglutide on the NIOSH List of Hazardous Drugs in Healthcare Settings,Supporting & Related Material,,2024-12-20T05:00:00Z,2024,12,,,2024-12-20T12:16:43Z,,0,0,090000648687b84e
CDC-2024-0100-0003,CDC,CDC-2024-0100,Appendices HIV Screening Recommendation,Supporting & Related Material,,2024-12-03T05:00:00Z,2024,12,,,2024-12-03T13:49:00Z,,0,0,09000064868470cb
CDC-2024-0100-0002,CDC,CDC-2024-0100,DRAFT HIV Screening Recommendations,Supporting & Related Material,,2024-12-03T05:00:00Z,2024,12,,,2024-12-03T13:48:22Z,,0,0,09000064868470bf
CDC-2024-0090-0002,CDC,CDC-2024-0090,VSP Construction Standards draft,Supporting & Related Material,,2024-10-30T04:00:00Z,2024,10,,,2024-10-30T13:52:16Z,,0,0,09000064867ebc11
CDC-2024-0090-0003,CDC,CDC-2024-0090,VSP Environmental Public Health Standards draft,Supporting & Related Material,,2024-10-30T04:00:00Z,2024,10,,,2024-10-30T13:52:36Z,,0,0,09000064867ebc12
CDC-2024-0085-0002,CDC,CDC-2024-0085,Draft - NIOSH Skin Notation Profile Picric Acid,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T11:32:30Z,,0,0,09000064867e0d11
CDC-2024-0085-0005,CDC,CDC-2024-0085,Draft - NIOSH Skin Notation Profile Formic acid,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T11:34:02Z,,0,0,09000064867e0cac
CDC-2024-0055-0004,CDC,CDC-2024-0055,NIOSH National Firefighter Registry Subcommittee August 2024 Meeting Minutes,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T19:23:25Z,,0,0,09000064867e9859
CDC-2024-0085-0003,CDC,CDC-2024-0085,Draft - NIOSH Skin Notation Profile Formamide,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T11:33:20Z,,0,0,09000064867e0caa
CDC-2024-0085-0006,CDC,CDC-2024-0085,Draft - NIOSH Skin Notation Profile Phenothiazine,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T11:34:31Z,,0,0,09000064867e0cad
CDC-2024-0085-0004,CDC,CDC-2024-0085,Draft - NIOSH Skin Notation Profile Allyl alcohol,Supporting & Related Material,,2024-10-28T04:00:00Z,2024,10,,,2024-10-28T11:33:40Z,,0,0,09000064867e0cab
CDC-2024-0055-0003,CDC,CDC-2024-0055,"Presentation: National Firefighter Registry (NFR) for Cancer: 
Overview & Update",Supporting & Related Material,,2024-09-23T04:00:00Z,2024,9,,,2024-09-23T18:44:08Z,,0,0,090000648676aca9
CDC-2024-0065-0002,CDC,CDC-2024-0065,Draft - NIOSH Hazard Review: Wildland Fire Smoke Exposure Among Farmworkers and Other Outdoor Workers,Supporting & Related Material,,2024-09-13T04:00:00Z,2024,9,,,2024-09-13T10:47:12Z,,0,0,09000064866eb040
CDC-2024-0064-0002,CDC,CDC-2024-0064,Meeting Agenda,Supporting & Related Material,,2024-09-03T04:00:00Z,2024,9,,,2024-09-03T12:11:10Z,,0,0,09000064866b0482
CDC-2024-0055-0002,CDC,CDC-2024-0055,Meeting Agenda,Supporting & Related Material,,2024-07-18T04:00:00Z,2024,7,,,2024-07-18T11:00:17Z,,0,0,09000064865f4bf0
CDC-2022-0066-0026,CDC,CDC-2022-0066,NIOSH Responses to Comments,Supporting & Related Material,,2024-05-23T04:00:00Z,2024,5,,,2024-05-23T13:16:48Z,,0,0,090000648657d1e2
CDC-2022-0066-0025,CDC,CDC-2022-0066,Final - NIOSH Healthcare Personal Protective Technology Targets for 2020 to 2030,Supporting & Related Material,,2024-05-17T04:00:00Z,2024,5,,,2024-05-17T18:18:19Z,,0,0,090000648656d5e5
CDC-2022-0066-0024,CDC,CDC-2022-0066,Final - NIOSH Healthcare Personal Protective Technology Targets for 2020 to 2030,Supporting & Related Material,,2024-05-17T00:00:00Z,2024,5,,,2024-05-17T18:23:26Z,,0,1,090000648656c466
CDC-2024-0005-0004,CDC,CDC-2024-0005,"NIOSH National Personal Protective Technology Laboratory [2024], Determination of Combination Unit Respirator (CUR) Performance During Dynamic Testing Against the Chemical Agent Sarin (GB) Vapor, Standard Testing Procedure (STP), CVB-CBRN-CUR-STP-0802",Supporting & Related Material,,2024-03-15T04:00:00Z,2024,3,,,2024-03-15T12:07:19Z,,0,0,090000648647c9dd
CDC-2024-0005-0006,CDC,CDC-2024-0005,"NIOSH National Personal Protective Technology Laboratory [2024], Determination of Gauge Line Flow Performance for Combination Unit Respirator (CUR) Systems Standard Testing Procedure (STP), CVB-CBRN-CUR-STP-0848",Supporting & Related Material,,2024-03-15T04:00:00Z,2024,3,,,2024-03-15T12:11:28Z,,0,0,090000648647c9db
CDC-2024-0005-0003,CDC,CDC-2024-0005,"NIOSH National Personal Protective Technology Laboratory [2024], Determination of Combination Unit Respirator (CUR) Performance During Dynamic Testing Against the Chemical Agent Mustard (HD) Liquid/Vapor, Standard Testing Procedure (STP), CVB-CBRN-CUR-STP-0801",Supporting & Related Material,,2024-03-15T04:00:00Z,2024,3,,,2024-03-15T12:04:24Z,,0,0,090000648647c9de
CDC-2024-0005-0005,CDC,CDC-2024-0005,"NIOSH National Personal Protective Technology Laboratory [2024], Determination of Combination Unit Respirator (CUR) Systems Mode Switching During Low-Temperature Operation, Standard Testing Procedure (STP), CVB-CBRN-CUR-STP-0819",Supporting & Related Material,,2024-03-15T04:00:00Z,2024,3,,,2024-03-15T12:09:56Z,,0,0,090000648647c9da
CDC-2024-0005-0002,CDC,CDC-2024-0005,"NIOSH National Personal Protective Technology Laboratory [2024], Determination of Laboratory Respirator Protection Level (LRPL) Values for Combination Unit Respirator (CUR), Standard Testing Procedure (STP), CVB-CBRN-CUR-STP-0800",Supporting & Related Material,,2024-03-15T04:00:00Z,2024,3,,,2024-03-15T12:00:48Z,,0,0,090000648647c9dc
CDC-2024-0014-0002,CDC,CDC-2024-0014,Draft-IC-in-HCP-GL-Update-CMV-Section,Supporting & Related Material,,2024-02-26T05:00:00Z,2024,2,,,2024-02-26T13:54:00Z,,0,0,090000648642de40
CDC-2024-0014-0003,CDC,CDC-2024-0014,Draft-IC-in-HCP-GL-Update-Parvo-Section,Supporting & Related Material,,2024-02-26T05:00:00Z,2024,2,,,2024-02-26T13:54:27Z,,0,0,090000648642e5b3
CDC-2024-0014-0004,CDC,CDC-2024-0014,Source_Control_Definition_IPCinHCPupdate,Supporting & Related Material,,2024-02-26T05:00:00Z,2024,2,,,2024-02-26T13:54:46Z,,0,0,090000648642e5b1
CDC-2024-0015-0002,CDC,CDC-2024-0015,Appendix A_VHF Updates,Supporting & Related Material,,2024-02-26T05:00:00Z,2024,2,,,2024-02-26T14:07:17Z,,0,0,090000648642df72
CDC-2024-0009-0002,CDC,CDC-2024-0009,Meeting Agenda,Supporting & Related Material,,2024-02-05T05:00:00Z,2024,2,,,2024-02-05T12:45:46Z,,0,0,09000064863d5a48
CDC-2020-0046-0142,CDC,CDC-2020-0046,"Draft - NIOSH Reevaluation of Liraglutide on the NIOSH List of Antineoplastic and Other Hazardous Drugs in 
Healthcare Settings",Supporting & Related Material,,2024-01-16T05:00:00Z,2024,1,,,2024-01-16T12:59:52Z,,0,0,090000648639e6e3
CDC-2020-0046-0143,CDC,CDC-2020-0046,"Draft - NIOSH Reevaluation of Pertuzumab on the NIOSH List of Antineoplastic and Other Hazardous Drugs in 
Healthcare Settings",Supporting & Related Material,,2024-01-16T05:00:00Z,2024,1,,,2024-01-16T13:05:05Z,,0,0,090000648639e704
CDC-2023-0080-0002,CDC,CDC-2023-0080,Supplemental material: Guidelines for the Use of Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection (STI) Prevention,Supporting & Related Material,,2023-10-02T04:00:00Z,2023,10,,,2023-10-18T20:19:25Z,,0,0,09000064860155c0
CDC-2023-0075-0002,CDC,CDC-2023-0075,National One Health Framework to Address Zoonotic Diseases and Advance Public Health Preparedness in the United States: A Framework for One Health Coordination and Collaboration across Federal Agencies,Supporting & Related Material,,2023-09-20T04:00:00Z,2023,9,,,2023-09-20T13:19:38Z,,0,0,0900006485fd6d44
CDC-2023-0031-0004,CDC,CDC-2023-0031,Presentation - National Firefighter Registry for Cancer:  Progress Report for NFR Subcommittee,Supporting & Related Material,,2023-08-25T04:00:00Z,2023,8,,,2023-08-25T12:46:53Z,,0,0,0900006485eeb0b6
CDC-2023-0031-0003,CDC,CDC-2023-0031,Meeting Minutes,Supporting & Related Material,,2023-08-25T04:00:00Z,2023,8,,,2023-08-25T12:39:23Z,,0,0,0900006485eeaf01
CDC-2023-0031-0005,CDC,CDC-2023-0031,National Firefighter Registry (NFR) - Protocol,Supporting & Related Material,,2023-08-25T04:00:00Z,2023,8,,,2023-08-25T13:24:08Z,,0,0,0900006485eea7df
CDC-2022-0078-0006,CDC,CDC-2022-0078,Revised - American Indian and Alaska Native Worker Safety and Health Strategic Plan,Supporting & Related Material,,2023-08-14T04:00:00Z,2023,8,,,2023-08-14T12:56:54Z,,0,0,0900006485e336f2
CDC-2023-0057-0002,CDC,CDC-2023-0057,Draft Immediately Dangerous to Life or Health (IDLH) Value Document for Hydrogen Chloride,Supporting & Related Material,,2023-08-10T04:00:00Z,2023,8,,,2023-08-10T10:55:49Z,,0,0,0900006485e0678e
CDC-2023-0015-0006,CDC,CDC-2023-0015,"The economics of worker safety, health, and well-being",Supporting & Related Material,,2023-07-28T04:00:00Z,2023,7,,,2023-07-28T15:58:15Z,,0,0,0900006485d6fc2c
CDC-2023-0015-0003,CDC,CDC-2023-0015,"April 21,2023 Meeting Minutes",Supporting & Related Material,,2023-07-28T04:00:00Z,2023,7,,,2023-07-28T15:41:29Z,,0,0,0900006485d6fbb8
CDC-2023-0015-0007,CDC,CDC-2023-0015,Publications by Economic Research and Support Office staff through 2022,Supporting & Related Material,,2023-07-28T04:00:00Z,2023,7,,,2023-07-28T16:09:55Z,,0,0,0900006485d6fc75
CDC-2023-0015-0008,CDC,CDC-2023-0015,Overview of Per- and Polyfluoroalkyl Substances (PFAS) Activities and Considerations,Supporting & Related Material,,2023-07-28T04:00:00Z,2023,7,,,2023-07-28T17:33:02Z,,0,0,0900006485d7226c
CDC-2023-0015-0004,CDC,CDC-2023-0015,NIOSH Director's Talking Points,Supporting & Related Material,,2023-07-28T04:00:00Z,2023,7,,,2023-07-28T15:44:38Z,,0,0,0900006485d6fbdd
CDC-2023-0015-0005,CDC,CDC-2023-0015,Overview of Per- and Polyfluoroalkyl Substances (PFAS) Activities and Considerations,Supporting & Related Material,,2023-07-28T00:00:00Z,2023,7,,,2023-07-28T17:29:50Z,,0,1,0900006485d6fc0b
CDC-2023-0062-0002,CDC,CDC-2023-0062,Draft-IC-in-HCP-GL-Update-MMRV-HCP-Sections,Supporting & Related Material,,2023-07-18T04:00:00Z,2023,7,,,2023-07-18T13:01:17Z,,0,0,0900006485cd2b00
CDC-2023-0051-0002,CDC,CDC-2023-0051,Regulatory Impact Analysis - Control of Communicable Diseases; Foreign Quarantine: Importation of Dogs and Cats,Supporting & Related Material,,2023-07-10T04:00:00Z,2023,7,,,2023-07-10T12:55:12Z,,0,0,0900006485c7dcf9
CDC-2023-0040-0010,CDC,CDC-2023-0040,Presentation: Youth Research Cohort,Supporting & Related Material,,2023-06-23T04:00:00Z,2023,6,,,2023-06-23T10:55:57Z,,0,0,0900006485bbea4f
CDC-2023-0040-0011,CDC,CDC-2023-0040,Presentation: Overview of Young Survivors: WTC Environmental Health Center,Supporting & Related Material,,2023-06-23T04:00:00Z,2023,6,,,2023-06-23T10:59:16Z,,0,0,0900006485bbea50
CDC-2023-0040-0013,CDC,CDC-2023-0040,Presentation: Response to STAC Recommendations on the P&P for Adding Non-Cancer Health Conditions to the List of WTC-Related Health Conditions,Supporting & Related Material,,2023-06-23T04:00:00Z,2023,6,,,2023-06-23T11:05:24Z,,0,0,0900006485bbea52
CDC-2023-0040-0012,CDC,CDC-2023-0040,Presentation: Young Survivors’ Views,Supporting & Related Material,,2023-06-23T04:00:00Z,2023,6,,,2023-06-23T11:02:27Z,,0,0,0900006485bbea51
CDC-2019-0093-0005,CDC,CDC-2019-0093,Draft - Immediately Dangerous to Life or Health (IDLH) Value Profile for Hydrogen Bromide,Supporting & Related Material,,2023-06-22T04:00:00Z,2023,6,,,2023-06-22T10:47:54Z,,0,0,0900006485a865bc
CDC-2019-0093-0004,CDC,CDC-2019-0093,Draft - Immediately Dangerous to Life or Health (IDLH) Value Profile for Hydrogen Iodide,Supporting & Related Material,,2023-06-22T04:00:00Z,2023,6,,,2023-06-22T10:47:27Z,,0,0,0900006485a865bb
CDC-2023-0040-0006,CDC,CDC-2023-0040,"Revised agenda for June 21, 2023, STAC meeting",Supporting & Related Material,,2023-06-21T04:00:00Z,2023,6,,,2023-06-21T14:44:43Z,,0,0,0900006485b9313d
CDC-2023-0040-0005,CDC,CDC-2023-0040,Revised Agenda,Supporting & Related Material,,2023-06-14T04:00:00Z,2023,6,,,2023-06-14T17:13:42Z,,0,0,0900006485b1abdd
CDC-2023-0040-0003,CDC,CDC-2023-0040,Meeting Agenda,Supporting & Related Material,,2023-05-26T04:00:00Z,2023,5,,,2023-05-26T15:44:44Z,,0,0,0900006485a71b6b
CDC-2023-0040-0002,CDC,CDC-2023-0040,Charge to STAC regarding the new youth research cohort being established by the World Trade Center Health Program,Supporting & Related Material,,2023-05-26T04:00:00Z,2023,5,,,2023-05-26T15:42:33Z,,0,0,0900006485a7153e
CDC-2022-0096-0003,CDC,CDC-2022-0096,National Firefighter Registry Protocol,Supporting & Related Material,,2023-05-04T04:00:00Z,2023,5,,,2023-05-04T14:19:35Z,,0,0,09000064859ca8f5
CDC-2022-0098-0008,CDC,CDC-2022-0098,NIOSH Communication Update,Supporting & Related Material,,2023-05-04T04:00:00Z,2023,5,,,2023-05-04T15:13:08Z,,0,0,09000064859cb75b
CDC-2022-0096-0004,CDC,CDC-2022-0096,Meeting minutes,Supporting & Related Material,,2023-05-04T04:00:00Z,2023,5,,,2023-05-04T14:22:14Z,,0,0,09000064859cb10b
CDC-2022-0096-0005,CDC,CDC-2022-0096,National Firefighter Registry: Status Report,Supporting & Related Material,,2023-05-04T04:00:00Z,2023,5,,,2023-05-04T14:24:46Z,,0,0,09000064859ca8fb
CDC-2023-0031-0002,CDC,CDC-2023-0031,Meeting Agenda,Supporting & Related Material,,2023-05-04T04:00:00Z,2023,5,,,2023-05-04T14:31:13Z,,0,0,09000064859cb126
CDC-2020-0046-0139,CDC,CDC-2020-0046,Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings,Supporting & Related Material,,2023-04-27T04:00:00Z,2023,4,,,2023-04-27T12:03:44Z,,0,0,090000648597cab1
CDC-2020-0046-0140,CDC,CDC-2020-0046,Managing Hazardous Drug Exposures: Information for Healthcare Settings,Supporting & Related Material,,2023-04-27T04:00:00Z,2023,4,,,2023-04-27T12:04:08Z,,0,0,090000648597d5a7
CDC-2023-0025-0003,CDC,CDC-2023-0025,Draft-IC-in-HCP-GL-Update-Pregnant-HCP-Section,Supporting & Related Material,,2023-04-26T04:00:00Z,2023,4,,,2023-04-26T12:44:17Z,,0,0,090000648598b20c
CDC-2023-0025-0002,CDC,CDC-2023-0025,Draft-IC-in-HCP-GL-Update-Pregnant-HCP-Section,Supporting & Related Material,,2023-04-26T00:00:00Z,2023,4,,,2023-04-26T13:18:35Z,,0,1,090000648598b208
CDC-2022-0098-0004,CDC,CDC-2022-0098,National Firefighter Registry: Status Report,Supporting & Related Material,,2023-04-18T04:00:00Z,2023,4,,,2023-04-18T11:57:36Z,,0,0,0900006485955b43
CDC-2022-0098-0003,CDC,CDC-2022-0098,NIOSH Director's Opening Remarks,Supporting & Related Material,,2023-04-18T04:00:00Z,2023,4,,,2023-04-18T11:54:35Z,,0,0,0900006485953dea
CDC-2022-0098-0007,CDC,CDC-2022-0098,"October 4,2022 Meeting Minutes",Supporting & Related Material,,2023-04-18T04:00:00Z,2023,4,,,2023-04-18T12:14:16Z,,0,0,0900006485955b47
CDC-2022-0098-0006,CDC,CDC-2022-0098,Implementation Science Research at NIOSH,Supporting & Related Material,,2023-04-18T04:00:00Z,2023,4,,,2023-04-18T12:04:23Z,,0,0,0900006485953dec
CDC-2022-0098-0005,CDC,CDC-2022-0098,NIOSH Evaluation Capacity-Building Plan (ECB) Fiscal Year 2022 Update,Supporting & Related Material,,2023-04-18T04:00:00Z,2023,4,,,2023-04-18T12:00:49Z,,0,0,0900006485955b45
CDC-2022-0044-0035,CDC,CDC-2022-0044,CDC-2022-0044_Public Comments and Responses,Supporting & Related Material,,2023-03-21T04:00:00Z,2023,3,,,2023-03-21T14:47:50Z,,0,0,0900006485810de0
CDC-2022-0078-0005,CDC,CDC-2022-0078,American Indian and Alaska Native Worker Safety and Health Strategic Plan,Supporting & Related Material,,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T11:09:29Z,,0,0,09000064857aa03d
CDC-2023-0015-0002,CDC,CDC-2023-0015,"Meeting Agenda - April 21, 2023",Supporting & Related Material,,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T19:28:57Z,,0,0,09000064857860d1
CDC-2022-0003-0015,CDC,CDC-2022-0003,FSAP BSL4-ABSL4 Policy_02.03.2023,Supporting & Related Material,,2023-02-10T05:00:00Z,2023,2,,,2023-02-10T16:44:42Z,,0,0,09000064856578a2
CDC-2022-0063-0019,CDC,CDC-2022-0063,Prevention Program Prioritization Guidelines 2022,Supporting & Related Material,,2023-01-25T05:00:00Z,2023,1,,,2023-01-25T17:45:21Z,,0,0,0900006485609b68
CDC-2022-0063-0018,CDC,CDC-2022-0063,Meeting Summary: Fire Service Suggestions and NIOSH Response and Fire Fighter Fatality Investigation,Supporting & Related Material,,2023-01-25T05:00:00Z,2023,1,,,2023-01-25T17:42:42Z,,0,0,0900006485609ea9
CDC-2022-0052-0034,CDC,CDC-2022-0052,Scientific Considerations for Addition of Uterine Cancer to the List of Covered Conditions by the World Trade Center Health Program (Final),Supporting & Related Material,,2023-01-18T05:00:00Z,2023,1,,,2023-01-18T13:42:40Z,,0,0,09000064855f57f1
CDC-2021-0053-0145,CDC,CDC-2021-0053,File1_Final_Report_of_MECFS_Systematic_Review,Supporting & Related Material,,2023-01-18T05:00:00Z,2023,1,,,2023-01-18T14:37:12Z,,0,0,09000064855f549f
CDC-2021-0053-0148,CDC,CDC-2021-0053,MECFS_Webpage_Systematic_Review_2023-01-17,Supporting & Related Material,,2023-01-18T05:00:00Z,2023,1,,,2023-01-18T14:39:04Z,,0,0,09000064855f5874
CDC-2021-0053-0146,CDC,CDC-2021-0053,File2_Final_Report_of_MECFS_Systematic_Review_Appendix,Supporting & Related Material,,2023-01-18T05:00:00Z,2023,1,,,2023-01-18T14:37:59Z,,0,0,09000064855f54a0
CDC-2021-0053-0147,CDC,CDC-2021-0053,File3_Public_Comments_Summary_EPC Responses,Supporting & Related Material,,2023-01-18T05:00:00Z,2023,1,,,2023-01-18T14:38:43Z,,0,0,09000064855f5861
CDC-2022-0070-0053,CDC,CDC-2022-0070,Final Guidelines for Examining Unusual Patterns of Cancer and Environmental Concerns,Supporting & Related Material,,2022-12-08T05:00:00Z,2022,12,,,2022-12-08T12:27:02Z,,0,0,0900006485524d61
CDC-2022-0116-0002,CDC,CDC-2022-0116,Draft Guidelines_CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children,Supporting & Related Material,,2022-11-22T05:00:00Z,2022,11,,,2022-11-22T14:06:31Z,,0,0,09000064854fbd1b
CDC-2022-0116-0003,CDC,CDC-2022-0116,Appendix and Supplementary Tables_CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children,Supporting & Related Material,,2022-11-22T05:00:00Z,2022,11,,,2022-11-22T14:06:41Z,,0,0,09000064854fbd1a
CDC-2022-0024-5549,CDC,CDC-2022-0024,CDC Response to Public Comments on the Draft 2022 Clinical Practice Guideline for Prescribing Opioids for Pain,Supporting & Related Material,,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T17:06:32Z,,0,0,09000064854f9111
CDC-2022-0024-5548,CDC,CDC-2022-0024,CDC Clinical Practice Guideline for Prescribing Opioids for Pain United States 2022,Supporting & Related Material,,2022-11-21T05:00:00Z,2022,11,,,2022-11-21T17:06:23Z,,0,0,09000064854f8bec